Study compares treatment effect on visual fields in eyes with retinopathy of prematurity

In patients with severe retinopathy of prematurity, intravitreal anti-VEGF injection only preserves significant peripheral vision compared with laser treatment, according to a presentation at the 2020 ASRS Virtual Meeting.

In this study, 6 eyes with retinopathy of prematurity were treated with laser and 12 eyes were treated with intravitreal anti-VEGF injection only. Standard automated perimetry was performed on all patients at 10 years old.

In both groups, regression of disease was seen after treatment. At 10 years old, patients in the laser-treated group had a significantly restricted visual field area compared to those in the anti-VEGF injection only treatment group.

Reference
Banker AS, et al. Results of perimetry at age of 10 years in severe ROP eyes receiving laser or anti-VEGF treatment as primary monotherapy. Presented at: 2020 ASRS Virtual Meeting.

Related Content

• Glaucoma

Review finds low adverse event rates for glaucoma stents

• Retina

Switching to aflibercept 8 mg extends treatment intervals in suboptimal nARMD responders

• Conference Roundup

Cryopreserved amniotic membrane significantly improves ocular surface integrity in patients with severe keratoconjunctivitis sicca and neurotrophic keratopathy

• Conference Roundup

CAM360 with a collagen shield provides rapid epithelial healing with better tolerability and safety than when used with bandage contact lenses

• Conference Roundup

Enhanced monofocal IOLs provide better intermediate vision with no rings or dysphotopsia

• Conference Roundup

Phase 1/2 CLARA study shows AURN001 improves BCVA compared with standard of care for corneal endothelial dysfunction